Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

hims & hers health - HIMS

HIMS

Close Chg Chg %
24.18 1.15 4.76%

Closed Market

25.33

+1.15 (4.76%)

Volume: 17.45M

Last Updated:

Nov 22, 2024, 4:00 PM EDT

Trade Now

Company Overview: hims & hers health - HIMS

HIMS Key Data

Open

$23.77

 Day Range

23.03 - 25.37

52 Week Range

8.03 - 30.43

 Market Cap

$5.28B

Shares Outstanding

218.48M

 Public Float

177.25M

Beta

1.06

 Rev. Per Employee

N/A

P/E Ratio

55.86

 EPS

$0.47

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

20.82M

  

HIMS Performance

1 Week
 
 25.00%
 
1 Month
 
 11.14%
 
3 Months
 
 44.35%
 
1 Year
 
 193.80%
 
5 Years
 
 143.69%
 

HIMS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 14
Full Ratings ➔

About hims & hers health - HIMS

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

HIMS At a Glance

Hims & Hers Health, Inc.
2269 Chestnut Street
San Francisco, California 94123
Phone 1-415-851-0195 Revenue 872.00M
Industry Medical/Nursing Services Net Income -23,546,000.00
Sector Health Services 2023 Sales Growth 65.491%
Fiscal Year-end 12 / 2024 Employees 1,046
View SEC Filings

HIMS Valuation

P/E Current 55.864
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 2.137
Price to Book Ratio 5.523
Price to Cash Flow Ratio 25.355
Enterprise Value to EBITDA -68.994
Enterprise Value to Sales 1.895
Total Debt to Enterprise Value 0.006

HIMS Efficiency

Revenue/Employee 833,652.008
Income Per Employee -22,510.516
Receivables Turnover 152.848
Total Asset Turnover 2.16

HIMS Liquidity

Current Ratio 2.996
Quick Ratio 2.742
Cash Ratio 2.498

HIMS Profitability

Gross Margin 80.898
Operating Margin -3.837
Pretax Margin -2.474
Net Margin -2.70
Return on Assets -5.832
Return on Equity -7.181
Return on Total Capital -6.652
Return on Invested Capital -7.049

HIMS Capital Structure

Total Debt to Total Equity 2.892
Total Debt to Total Capital 2.81
Total Debt to Total Assets 2.255
Long-Term Debt to Equity 2.519
Long-Term Debt to Total Capital 2.448
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Hims & Hers Health - HIMS

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
- 271.88M 526.92M 872.00M
Sales Growth
- - +93.81% +65.49%
-
Cost of Goods Sold (COGS) incl D&A
- 71.46M 125.67M 166.57M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- 4.08M 7.47M 9.52M
Depreciation
- 1.98M 3.37M 6.01M
Amortization of Intangibles
- 2.10M 4.10M 3.50M
COGS Growth
- - +75.86% +32.54%
-
Gross Income
- 200.42M 401.25M 705.43M
Gross Income Growth
- - +100.20% +75.81%
-
Gross Profit Margin
- +73.72% +76.15% +80.90%
2020 2021 2022 2023 5-year trend
SG&A Expense
4.79M 315.46M 469.72M 738.89M
Research & Development
- - - -
-
Other SG&A
4.79M 315.46M 469.72M 738.89M
SGA Growth
+574.82% +6,483.45% +48.90% +57.30%
Other Operating Expense
- - - -
-
Unusual Expense
37.22M (3.80M) 151.00K (2.93M)
EBIT after Unusual Expense
(42.01M) (111.24M) (68.63M) (30.53M)
Non Operating Income/Expense
1.74M 445.00K 2.92M 8.96M
Non-Operating Interest Income
- - - 1.74M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(40.27M) (110.80M) (65.71M) (21.57M)
Pretax Income Growth
-3,610.18% -175.12% +40.69% +67.17%
Pretax Margin
- -40.75% -12.47% -2.47%
Income Tax
- (3.14M) (31.00K) 1.98M
Income Tax - Current - Domestic
- 252.00K 563.00K 1.99M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (3.25M) (449.00K) (13.00K)
Income Tax - Deferred - Foreign
- - (142.00K) (145.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(40.27M) (107.66M) (65.68M) (23.55M)
Minority Interest Expense
- - - -
-
Net Income
(40.27M) (107.66M) (65.68M) (23.55M)
Net Income Growth
-3,610.18% -167.34% +38.99% +64.15%
Net Margin Growth
- -39.60% -12.46% -2.70%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(40.27M) (107.66M) (65.68M) (23.55M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(40.27M) (107.66M) (65.68M) (23.55M)
EPS (Basic)
-1.6008 -0.5764 -0.3211 -0.1125
EPS (Basic) Growth
-3,610.53% +63.99% +44.29% +64.96%
Basic Shares Outstanding
25.16M 186.78M 204.52M 209.34M
EPS (Diluted)
-1.6008 -0.5764 -0.3211 -0.1125
EPS (Diluted) Growth
-3,610.53% +63.99% +44.29% +64.96%
Diluted Shares Outstanding
25.16M 186.78M 204.52M 209.34M
EBITDA
(4.79M) (110.97M) (61.00M) (23.95M)
EBITDA Growth
-574.82% -2,215.80% +45.03% +60.75%
EBITDA Margin
- -40.81% -11.58% -2.75%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 25.923
Number of Ratings 14 Current Quarters Estimate 0.178
FY Report Date 12 / 2024 Current Year's Estimate 0.797
Last Quarter’s Earnings 0.32 Median PE on CY Estimate N/A
Year Ago Earnings -0.11 Next Fiscal Year Estimate 0.888
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 3 8 8
Mean Estimate 0.18 0.16 0.80 0.89
High Estimates 0.28 0.24 0.99 1.24
Low Estimate 0.02 0.06 0.53 0.30
Coefficient of Variance 46.55 56.89 27.50 34.28

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 5 6 6
OVERWEIGHT 1 0 0
HOLD 7 7 8
UNDERWEIGHT 1 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Hims & Hers Health - HIMS

Date Name Shares Transaction Value
Nov 8, 2024 Mike Chi Chief Commercial Officer 196,034 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $11.53 per share 2,260,272.02
Nov 8, 2024 Andrew Dudum Chief Executive Officer; Director 519,004 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $21.19 per share 10,997,694.76
Nov 8, 2024 Andrew Dudum Chief Executive Officer; Director 92,118 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $21.19 per share 1,951,980.42
Nov 8, 2024 Andrew Dudum Chief Executive Officer; Director 506,602 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $21.76 per share 11,023,659.52
Nov 8, 2024 Patrick Carroll Chief Medical Officer; Director 196,941 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22.07 per share 4,346,487.87
Nov 8, 2024 Andrew Dudum Chief Executive Officer; Director 255,903 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $2.43 per share 621,844.29
Nov 8, 2024 Andrew Dudum Chief Executive Officer; Director 569,932 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $20.07 per share 11,438,535.24
Nov 8, 2024 Andrew Dudum Chief Executive Officer; Director 192,105 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $20.05 per share 3,851,705.25
Nov 8, 2024 Mike Chi Chief Commercial Officer 193,980 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $22 per share 4,267,560.00
Nov 8, 2024 Andrew Dudum Chief Executive Officer; Director 67,015 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $21.76 per share 1,458,246.40
Nov 8, 2024 Mike Chi Chief Commercial Officer 57,519 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Nov 8, 2024 Andrew Dudum Chief Executive Officer; Director 204,016 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 4, 2024 Andrew Dudum Chief Executive Officer; Director 392,904 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 4, 2024 Oluyemi Okupe Chief Financial Officer 217,437 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $5.01 per share 1,089,359.37
Oct 4, 2024 Oluyemi Okupe Chief Financial Officer 827,847 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Oct 4, 2024 Oluyemi Okupe Chief Financial Officer 205,856 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $19.08 per share 3,927,732.48
Oct 4, 2024 Soleil Boughton Chief Legal Officer 174,613 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $18.5 per share 3,230,340.50
Oct 4, 2024 Oluyemi Okupe Chief Financial Officer 208,244 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $18.88 per share 3,931,646.72
Oct 4, 2024 Oluyemi Okupe Chief Financial Officer 206,853 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $19.04 per share 3,938,481.12
Aug 20, 2024 Irene A. Becklund PAO 3,385 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $9.41 per share 31,852.85

Hims & Hers Health in the News